nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibuprofen—PPARG—liver cancer	0.247	0.727	CbGaD
Ibuprofen—ALB—liver cancer	0.093	0.273	CbGaD
Ibuprofen—UGT2B7—Epirubicin—liver cancer	0.0724	0.187	CbGbCtD
Ibuprofen—UGT1A9—Sorafenib—liver cancer	0.067	0.173	CbGbCtD
Ibuprofen—ABCC4—Sorafenib—liver cancer	0.056	0.145	CbGbCtD
Ibuprofen—UGT1A1—Sorafenib—liver cancer	0.0548	0.142	CbGbCtD
Ibuprofen—ABCC1—Epirubicin—liver cancer	0.0514	0.133	CbGbCtD
Ibuprofen—ABCC1—Doxorubicin—liver cancer	0.0273	0.0706	CbGbCtD
Ibuprofen—CYP2C8—Sorafenib—liver cancer	0.0161	0.0415	CbGbCtD
Ibuprofen—CYP2C19—Sorafenib—liver cancer	0.0135	0.0348	CbGbCtD
Ibuprofen—CYP2C9—Sorafenib—liver cancer	0.0112	0.0289	CbGbCtD
Ibuprofen—ABCB1—Sorafenib—liver cancer	0.0109	0.0281	CbGbCtD
Ibuprofen—ABCB1—Doxorubicin—liver cancer	0.00659	0.017	CbGbCtD
Ibuprofen—L-Tyrosine—TAT—liver cancer	0.00265	0.861	CrCbGaD
Ibuprofen—FABP2—embryo—liver cancer	0.00253	0.178	CbGeAlD
Ibuprofen—CFTR—gall bladder—liver cancer	0.00182	0.128	CbGeAlD
Ibuprofen—ALB—gall bladder—liver cancer	0.00081	0.0571	CbGeAlD
Ibuprofen—UGT2B4—liver—liver cancer	0.000753	0.0531	CbGeAlD
Ibuprofen—THBD—liver—liver cancer	0.000748	0.0527	CbGeAlD
Ibuprofen—UGT1A3—liver—liver cancer	0.000722	0.0509	CbGeAlD
Ibuprofen—PPARG—embryo—liver cancer	0.000547	0.0386	CbGeAlD
Ibuprofen—CFTR—liver—liver cancer	0.000533	0.0376	CbGeAlD
Ibuprofen—PLAT—liver—liver cancer	0.000527	0.0371	CbGeAlD
Ibuprofen—UGT1A9—liver—liver cancer	0.000515	0.0363	CbGeAlD
Ibuprofen—CXCL8—liver—liver cancer	0.000488	0.0344	CbGeAlD
Ibuprofen—PTGS2—gall bladder—liver cancer	0.000441	0.0311	CbGeAlD
Ibuprofen—UGT2B7—liver—liver cancer	0.000415	0.0292	CbGeAlD
Ibuprofen—SLC22A11—liver—liver cancer	0.000404	0.0285	CbGeAlD
Ibuprofen—UGT1A1—liver—liver cancer	0.000353	0.0249	CbGeAlD
Ibuprofen—PTGS2—embryo—liver cancer	0.00028	0.0197	CbGeAlD
Ibuprofen—SLCO2B1—liver—liver cancer	0.000259	0.0183	CbGeAlD
Ibuprofen—PPARG—liver—liver cancer	0.000253	0.0178	CbGeAlD
Ibuprofen—SLCO1A2—liver—liver cancer	0.000239	0.0168	CbGeAlD
Ibuprofen—ALB—liver—liver cancer	0.000237	0.0167	CbGeAlD
Ibuprofen—ABCC4—liver—liver cancer	0.00023	0.0162	CbGeAlD
Ibuprofen—ABCC1—liver—liver cancer	0.000196	0.0138	CbGeAlD
Ibuprofen—CYP2C19—liver—liver cancer	0.000191	0.0135	CbGeAlD
Ibuprofen—ABCB1—embryo—liver cancer	0.000173	0.0122	CbGeAlD
Ibuprofen—CYP2C8—liver—liver cancer	0.000167	0.0118	CbGeAlD
Ibuprofen—Fenoprofen—ALB—liver cancer	0.000166	0.0541	CrCbGaD
Ibuprofen—Renal impairment—Doxorubicin—liver cancer	0.000163	0.00154	CcSEcCtD
Ibuprofen—Dermatitis bullous—Doxorubicin—liver cancer	0.000163	0.00153	CcSEcCtD
Ibuprofen—Purpura—Doxorubicin—liver cancer	0.000161	0.00152	CcSEcCtD
Ibuprofen—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000161	0.00151	CcSEcCtD
Ibuprofen—Asthenia—Sorafenib—liver cancer	0.00016	0.00151	CcSEcCtD
Ibuprofen—Hypoglycaemia—Doxorubicin—liver cancer	0.000159	0.0015	CcSEcCtD
Ibuprofen—Cardiac failure—Doxorubicin—liver cancer	0.000159	0.0015	CcSEcCtD
Ibuprofen—Mood swings—Epirubicin—liver cancer	0.000159	0.0015	CcSEcCtD
Ibuprofen—Cerebrovascular accident—Doxorubicin—liver cancer	0.000159	0.00149	CcSEcCtD
Ibuprofen—Pruritus—Sorafenib—liver cancer	0.000158	0.00149	CcSEcCtD
Ibuprofen—Blood creatinine increased—Epirubicin—liver cancer	0.000157	0.00148	CcSEcCtD
Ibuprofen—Hyponatraemia—Doxorubicin—liver cancer	0.000156	0.00147	CcSEcCtD
Ibuprofen—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000155	0.00146	CcSEcCtD
Ibuprofen—Diplopia—Doxorubicin—liver cancer	0.000155	0.00146	CcSEcCtD
Ibuprofen—Liver function test abnormal—Epirubicin—liver cancer	0.000155	0.00146	CcSEcCtD
Ibuprofen—Abdominal pain upper—Epirubicin—liver cancer	0.000153	0.00144	CcSEcCtD
Ibuprofen—Affect lability—Doxorubicin—liver cancer	0.000153	0.00144	CcSEcCtD
Ibuprofen—Hypokalaemia—Epirubicin—liver cancer	0.000153	0.00144	CcSEcCtD
Ibuprofen—Diarrhoea—Sorafenib—liver cancer	0.000153	0.00144	CcSEcCtD
Ibuprofen—Naproxen—ALB—liver cancer	0.000152	0.0492	CrCbGaD
Ibuprofen—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000151	0.00142	CcSEcCtD
Ibuprofen—Gastritis—Epirubicin—liver cancer	0.000149	0.0014	CcSEcCtD
Ibuprofen—CYP2C9—liver—liver cancer	0.000148	0.0104	CbGeAlD
Ibuprofen—Dizziness—Sorafenib—liver cancer	0.000148	0.00139	CcSEcCtD
Ibuprofen—Mood swings—Doxorubicin—liver cancer	0.000147	0.00139	CcSEcCtD
Ibuprofen—Abdominal distension—Epirubicin—liver cancer	0.000146	0.00138	CcSEcCtD
Ibuprofen—Blood creatinine increased—Doxorubicin—liver cancer	0.000146	0.00137	CcSEcCtD
Ibuprofen—Asthma—Epirubicin—liver cancer	0.000145	0.00137	CcSEcCtD
Ibuprofen—Dysphagia—Epirubicin—liver cancer	0.000145	0.00137	CcSEcCtD
Ibuprofen—Influenza—Epirubicin—liver cancer	0.000145	0.00137	CcSEcCtD
Ibuprofen—Eosinophilia—Epirubicin—liver cancer	0.000144	0.00135	CcSEcCtD
Ibuprofen—Liver function test abnormal—Doxorubicin—liver cancer	0.000143	0.00135	CcSEcCtD
Ibuprofen—Pancreatitis—Epirubicin—liver cancer	0.000142	0.00134	CcSEcCtD
Ibuprofen—Vomiting—Sorafenib—liver cancer	0.000142	0.00134	CcSEcCtD
Ibuprofen—Abdominal pain upper—Doxorubicin—liver cancer	0.000142	0.00134	CcSEcCtD
Ibuprofen—Hypokalaemia—Doxorubicin—liver cancer	0.000141	0.00133	CcSEcCtD
Ibuprofen—Rash—Sorafenib—liver cancer	0.000141	0.00133	CcSEcCtD
Ibuprofen—Dermatitis—Sorafenib—liver cancer	0.000141	0.00132	CcSEcCtD
Ibuprofen—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00014	0.00132	CcSEcCtD
Ibuprofen—Headache—Sorafenib—liver cancer	0.00014	0.00132	CcSEcCtD
Ibuprofen—Bronchitis—Epirubicin—liver cancer	0.00014	0.00131	CcSEcCtD
Ibuprofen—Pancytopenia—Epirubicin—liver cancer	0.000138	0.0013	CcSEcCtD
Ibuprofen—Gastritis—Doxorubicin—liver cancer	0.000138	0.00129	CcSEcCtD
Ibuprofen—Dysuria—Epirubicin—liver cancer	0.000136	0.00128	CcSEcCtD
Ibuprofen—Neutropenia—Epirubicin—liver cancer	0.000136	0.00128	CcSEcCtD
Ibuprofen—Abdominal distension—Doxorubicin—liver cancer	0.000135	0.00127	CcSEcCtD
Ibuprofen—Influenza—Doxorubicin—liver cancer	0.000134	0.00126	CcSEcCtD
Ibuprofen—Dysphagia—Doxorubicin—liver cancer	0.000134	0.00126	CcSEcCtD
Ibuprofen—Asthma—Doxorubicin—liver cancer	0.000134	0.00126	CcSEcCtD
Ibuprofen—Pollakiuria—Epirubicin—liver cancer	0.000134	0.00126	CcSEcCtD
Ibuprofen—Eosinophilia—Doxorubicin—liver cancer	0.000133	0.00125	CcSEcCtD
Ibuprofen—Nausea—Sorafenib—liver cancer	0.000133	0.00125	CcSEcCtD
Ibuprofen—Photosensitivity reaction—Epirubicin—liver cancer	0.000132	0.00125	CcSEcCtD
Ibuprofen—Pancreatitis—Doxorubicin—liver cancer	0.000132	0.00124	CcSEcCtD
Ibuprofen—Weight decreased—Epirubicin—liver cancer	0.000131	0.00124	CcSEcCtD
Ibuprofen—Hyperglycaemia—Epirubicin—liver cancer	0.000131	0.00123	CcSEcCtD
Ibuprofen—Pneumonia—Epirubicin—liver cancer	0.00013	0.00122	CcSEcCtD
Ibuprofen—Drowsiness—Epirubicin—liver cancer	0.000129	0.00122	CcSEcCtD
Ibuprofen—PTGS2—liver—liver cancer	0.000129	0.00912	CbGeAlD
Ibuprofen—Bronchitis—Doxorubicin—liver cancer	0.000129	0.00122	CcSEcCtD
Ibuprofen—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000128	0.00121	CcSEcCtD
Ibuprofen—Pancytopenia—Doxorubicin—liver cancer	0.000128	0.0012	CcSEcCtD
Ibuprofen—Renal failure—Epirubicin—liver cancer	0.000127	0.0012	CcSEcCtD
Ibuprofen—Neuropathy peripheral—Epirubicin—liver cancer	0.000127	0.00119	CcSEcCtD
Ibuprofen—Jaundice—Epirubicin—liver cancer	0.000126	0.00119	CcSEcCtD
Ibuprofen—Stomatitis—Epirubicin—liver cancer	0.000126	0.00119	CcSEcCtD
Ibuprofen—Conjunctivitis—Epirubicin—liver cancer	0.000126	0.00118	CcSEcCtD
Ibuprofen—Urinary tract infection—Epirubicin—liver cancer	0.000126	0.00118	CcSEcCtD
Ibuprofen—Neutropenia—Doxorubicin—liver cancer	0.000126	0.00118	CcSEcCtD
Ibuprofen—Dysuria—Doxorubicin—liver cancer	0.000126	0.00118	CcSEcCtD
Ibuprofen—Sweating—Epirubicin—liver cancer	0.000124	0.00117	CcSEcCtD
Ibuprofen—Pollakiuria—Doxorubicin—liver cancer	0.000124	0.00117	CcSEcCtD
Ibuprofen—Haematuria—Epirubicin—liver cancer	0.000123	0.00116	CcSEcCtD
Ibuprofen—Photosensitivity reaction—Doxorubicin—liver cancer	0.000123	0.00115	CcSEcCtD
Ibuprofen—Hepatobiliary disease—Epirubicin—liver cancer	0.000122	0.00115	CcSEcCtD
Ibuprofen—Epistaxis—Epirubicin—liver cancer	0.000122	0.00115	CcSEcCtD
Ibuprofen—Weight decreased—Doxorubicin—liver cancer	0.000122	0.00114	CcSEcCtD
Ibuprofen—Sinusitis—Epirubicin—liver cancer	0.000121	0.00114	CcSEcCtD
Ibuprofen—Hyperglycaemia—Doxorubicin—liver cancer	0.000121	0.00114	CcSEcCtD
Ibuprofen—Agranulocytosis—Epirubicin—liver cancer	0.000121	0.00114	CcSEcCtD
Ibuprofen—Pneumonia—Doxorubicin—liver cancer	0.00012	0.00113	CcSEcCtD
Ibuprofen—Drowsiness—Doxorubicin—liver cancer	0.00012	0.00113	CcSEcCtD
Ibuprofen—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000119	0.00112	CcSEcCtD
Ibuprofen—Renal failure—Doxorubicin—liver cancer	0.000118	0.00111	CcSEcCtD
Ibuprofen—Neuropathy peripheral—Doxorubicin—liver cancer	0.000117	0.0011	CcSEcCtD
Ibuprofen—Haemoglobin—Epirubicin—liver cancer	0.000117	0.0011	CcSEcCtD
Ibuprofen—Jaundice—Doxorubicin—liver cancer	0.000117	0.0011	CcSEcCtD
Ibuprofen—Stomatitis—Doxorubicin—liver cancer	0.000117	0.0011	CcSEcCtD
Ibuprofen—Rhinitis—Epirubicin—liver cancer	0.000116	0.0011	CcSEcCtD
Ibuprofen—Conjunctivitis—Doxorubicin—liver cancer	0.000116	0.0011	CcSEcCtD
Ibuprofen—Urinary tract infection—Doxorubicin—liver cancer	0.000116	0.0011	CcSEcCtD
Ibuprofen—Haemorrhage—Epirubicin—liver cancer	0.000116	0.00109	CcSEcCtD
Ibuprofen—Hepatitis—Epirubicin—liver cancer	0.000116	0.00109	CcSEcCtD
Ibuprofen—Pharyngitis—Epirubicin—liver cancer	0.000115	0.00109	CcSEcCtD
Ibuprofen—Sweating—Doxorubicin—liver cancer	0.000115	0.00108	CcSEcCtD
Ibuprofen—Urinary tract disorder—Epirubicin—liver cancer	0.000115	0.00108	CcSEcCtD
Ibuprofen—Oedema peripheral—Epirubicin—liver cancer	0.000114	0.00108	CcSEcCtD
Ibuprofen—Haematuria—Doxorubicin—liver cancer	0.000114	0.00107	CcSEcCtD
Ibuprofen—Urethral disorder—Epirubicin—liver cancer	0.000114	0.00107	CcSEcCtD
Ibuprofen—Hepatobiliary disease—Doxorubicin—liver cancer	0.000113	0.00107	CcSEcCtD
Ibuprofen—Epistaxis—Doxorubicin—liver cancer	0.000113	0.00106	CcSEcCtD
Ibuprofen—Sinusitis—Doxorubicin—liver cancer	0.000112	0.00106	CcSEcCtD
Ibuprofen—Visual impairment—Epirubicin—liver cancer	0.000112	0.00105	CcSEcCtD
Ibuprofen—Agranulocytosis—Doxorubicin—liver cancer	0.000112	0.00105	CcSEcCtD
Ibuprofen—Erythema multiforme—Epirubicin—liver cancer	0.00011	0.00103	CcSEcCtD
Ibuprofen—Flurbiprofen—ALB—liver cancer	0.000109	0.0353	CrCbGaD
Ibuprofen—Tinnitus—Epirubicin—liver cancer	0.000108	0.00102	CcSEcCtD
Ibuprofen—Haemoglobin—Doxorubicin—liver cancer	0.000108	0.00102	CcSEcCtD
Ibuprofen—Rhinitis—Doxorubicin—liver cancer	0.000108	0.00101	CcSEcCtD
Ibuprofen—Haemorrhage—Doxorubicin—liver cancer	0.000108	0.00101	CcSEcCtD
Ibuprofen—Hepatitis—Doxorubicin—liver cancer	0.000108	0.00101	CcSEcCtD
Ibuprofen—Pharyngitis—Doxorubicin—liver cancer	0.000107	0.001	CcSEcCtD
Ibuprofen—Urinary tract disorder—Doxorubicin—liver cancer	0.000106	0.000999	CcSEcCtD
Ibuprofen—Oedema peripheral—Doxorubicin—liver cancer	0.000106	0.000997	CcSEcCtD
Ibuprofen—Urethral disorder—Doxorubicin—liver cancer	0.000105	0.000992	CcSEcCtD
Ibuprofen—Immune system disorder—Epirubicin—liver cancer	0.000105	0.000987	CcSEcCtD
Ibuprofen—Mediastinal disorder—Epirubicin—liver cancer	0.000105	0.000985	CcSEcCtD
Ibuprofen—Chills—Epirubicin—liver cancer	0.000104	0.000981	CcSEcCtD
Ibuprofen—Arrhythmia—Epirubicin—liver cancer	0.000104	0.000977	CcSEcCtD
Ibuprofen—Visual impairment—Doxorubicin—liver cancer	0.000104	0.000975	CcSEcCtD
Ibuprofen—Alopecia—Epirubicin—liver cancer	0.000103	0.000966	CcSEcCtD
Ibuprofen—Mental disorder—Epirubicin—liver cancer	0.000102	0.000958	CcSEcCtD
Ibuprofen—Erythema multiforme—Doxorubicin—liver cancer	0.000102	0.000956	CcSEcCtD
Ibuprofen—Erythema—Epirubicin—liver cancer	0.000101	0.000952	CcSEcCtD
Ibuprofen—Malnutrition—Epirubicin—liver cancer	0.000101	0.000952	CcSEcCtD
Ibuprofen—Tinnitus—Doxorubicin—liver cancer	0.0001	0.000943	CcSEcCtD
Ibuprofen—Flatulence—Epirubicin—liver cancer	9.97e-05	0.000938	CcSEcCtD
Ibuprofen—Tension—Epirubicin—liver cancer	9.92e-05	0.000934	CcSEcCtD
Ibuprofen—Dysgeusia—Epirubicin—liver cancer	9.9e-05	0.000932	CcSEcCtD
Ibuprofen—Nervousness—Epirubicin—liver cancer	9.82e-05	0.000924	CcSEcCtD
Ibuprofen—Muscle spasms—Epirubicin—liver cancer	9.72e-05	0.000915	CcSEcCtD
Ibuprofen—Immune system disorder—Doxorubicin—liver cancer	9.71e-05	0.000914	CcSEcCtD
Ibuprofen—Mediastinal disorder—Doxorubicin—liver cancer	9.69e-05	0.000912	CcSEcCtD
Ibuprofen—Chills—Doxorubicin—liver cancer	9.65e-05	0.000908	CcSEcCtD
Ibuprofen—Arrhythmia—Doxorubicin—liver cancer	9.6e-05	0.000904	CcSEcCtD
Ibuprofen—Vision blurred—Epirubicin—liver cancer	9.53e-05	0.000897	CcSEcCtD
Ibuprofen—Alopecia—Doxorubicin—liver cancer	9.5e-05	0.000894	CcSEcCtD
Ibuprofen—Mental disorder—Doxorubicin—liver cancer	9.42e-05	0.000886	CcSEcCtD
Ibuprofen—Ill-defined disorder—Epirubicin—liver cancer	9.38e-05	0.000883	CcSEcCtD
Ibuprofen—Malnutrition—Doxorubicin—liver cancer	9.36e-05	0.000881	CcSEcCtD
Ibuprofen—Erythema—Doxorubicin—liver cancer	9.36e-05	0.000881	CcSEcCtD
Ibuprofen—Anaemia—Epirubicin—liver cancer	9.35e-05	0.00088	CcSEcCtD
Ibuprofen—Agitation—Epirubicin—liver cancer	9.29e-05	0.000875	CcSEcCtD
Ibuprofen—Flatulence—Doxorubicin—liver cancer	9.22e-05	0.000868	CcSEcCtD
Ibuprofen—Tension—Doxorubicin—liver cancer	9.18e-05	0.000864	CcSEcCtD
Ibuprofen—Dysgeusia—Doxorubicin—liver cancer	9.16e-05	0.000862	CcSEcCtD
Ibuprofen—Malaise—Epirubicin—liver cancer	9.12e-05	0.000858	CcSEcCtD
Ibuprofen—Nervousness—Doxorubicin—liver cancer	9.09e-05	0.000855	CcSEcCtD
Ibuprofen—Vertigo—Epirubicin—liver cancer	9.09e-05	0.000855	CcSEcCtD
Ibuprofen—Syncope—Epirubicin—liver cancer	9.07e-05	0.000853	CcSEcCtD
Ibuprofen—Leukopenia—Epirubicin—liver cancer	9.05e-05	0.000852	CcSEcCtD
Ibuprofen—Muscle spasms—Doxorubicin—liver cancer	9e-05	0.000847	CcSEcCtD
Ibuprofen—Palpitations—Epirubicin—liver cancer	8.94e-05	0.000841	CcSEcCtD
Ibuprofen—Loss of consciousness—Epirubicin—liver cancer	8.89e-05	0.000836	CcSEcCtD
Ibuprofen—Cough—Epirubicin—liver cancer	8.83e-05	0.00083	CcSEcCtD
Ibuprofen—Vision blurred—Doxorubicin—liver cancer	8.82e-05	0.00083	CcSEcCtD
Ibuprofen—Convulsion—Epirubicin—liver cancer	8.76e-05	0.000825	CcSEcCtD
Ibuprofen—Hypertension—Epirubicin—liver cancer	8.73e-05	0.000822	CcSEcCtD
Ibuprofen—Ill-defined disorder—Doxorubicin—liver cancer	8.68e-05	0.000817	CcSEcCtD
Ibuprofen—Anaemia—Doxorubicin—liver cancer	8.65e-05	0.000814	CcSEcCtD
Ibuprofen—Myalgia—Epirubicin—liver cancer	8.61e-05	0.00081	CcSEcCtD
Ibuprofen—Arthralgia—Epirubicin—liver cancer	8.61e-05	0.00081	CcSEcCtD
Ibuprofen—Agitation—Doxorubicin—liver cancer	8.6e-05	0.000809	CcSEcCtD
Ibuprofen—Anxiety—Epirubicin—liver cancer	8.58e-05	0.000807	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	8.55e-05	0.000805	CcSEcCtD
Ibuprofen—Discomfort—Epirubicin—liver cancer	8.51e-05	0.000801	CcSEcCtD
Ibuprofen—Malaise—Doxorubicin—liver cancer	8.44e-05	0.000794	CcSEcCtD
Ibuprofen—Dry mouth—Epirubicin—liver cancer	8.42e-05	0.000792	CcSEcCtD
Ibuprofen—Vertigo—Doxorubicin—liver cancer	8.41e-05	0.000791	CcSEcCtD
Ibuprofen—Syncope—Doxorubicin—liver cancer	8.39e-05	0.00079	CcSEcCtD
Ibuprofen—Leukopenia—Doxorubicin—liver cancer	8.38e-05	0.000788	CcSEcCtD
Ibuprofen—Confusional state—Epirubicin—liver cancer	8.32e-05	0.000783	CcSEcCtD
Ibuprofen—Palpitations—Doxorubicin—liver cancer	8.27e-05	0.000778	CcSEcCtD
Ibuprofen—Anaphylactic shock—Epirubicin—liver cancer	8.25e-05	0.000777	CcSEcCtD
Ibuprofen—Oedema—Epirubicin—liver cancer	8.25e-05	0.000777	CcSEcCtD
Ibuprofen—Loss of consciousness—Doxorubicin—liver cancer	8.23e-05	0.000774	CcSEcCtD
Ibuprofen—Infection—Epirubicin—liver cancer	8.2e-05	0.000772	CcSEcCtD
Ibuprofen—Cough—Doxorubicin—liver cancer	8.17e-05	0.000768	CcSEcCtD
Ibuprofen—Shock—Epirubicin—liver cancer	8.12e-05	0.000764	CcSEcCtD
Ibuprofen—Convulsion—Doxorubicin—liver cancer	8.11e-05	0.000763	CcSEcCtD
Ibuprofen—Nervous system disorder—Epirubicin—liver cancer	8.09e-05	0.000762	CcSEcCtD
Ibuprofen—Thrombocytopenia—Epirubicin—liver cancer	8.08e-05	0.00076	CcSEcCtD
Ibuprofen—Hypertension—Doxorubicin—liver cancer	8.08e-05	0.00076	CcSEcCtD
Ibuprofen—Tachycardia—Epirubicin—liver cancer	8.06e-05	0.000758	CcSEcCtD
Ibuprofen—Skin disorder—Epirubicin—liver cancer	8.02e-05	0.000754	CcSEcCtD
Ibuprofen—ABCB1—liver—liver cancer	8e-05	0.00564	CbGeAlD
Ibuprofen—Hyperhidrosis—Epirubicin—liver cancer	7.98e-05	0.000751	CcSEcCtD
Ibuprofen—Myalgia—Doxorubicin—liver cancer	7.97e-05	0.00075	CcSEcCtD
Ibuprofen—Arthralgia—Doxorubicin—liver cancer	7.97e-05	0.00075	CcSEcCtD
Ibuprofen—Anxiety—Doxorubicin—liver cancer	7.94e-05	0.000747	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	7.91e-05	0.000745	CcSEcCtD
Ibuprofen—Discomfort—Doxorubicin—liver cancer	7.87e-05	0.000741	CcSEcCtD
Ibuprofen—Anorexia—Epirubicin—liver cancer	7.87e-05	0.00074	CcSEcCtD
Ibuprofen—Dry mouth—Doxorubicin—liver cancer	7.79e-05	0.000733	CcSEcCtD
Ibuprofen—Hypotension—Epirubicin—liver cancer	7.71e-05	0.000726	CcSEcCtD
Ibuprofen—Confusional state—Doxorubicin—liver cancer	7.7e-05	0.000725	CcSEcCtD
Ibuprofen—Anaphylactic shock—Doxorubicin—liver cancer	7.64e-05	0.000719	CcSEcCtD
Ibuprofen—Oedema—Doxorubicin—liver cancer	7.64e-05	0.000719	CcSEcCtD
Ibuprofen—Infection—Doxorubicin—liver cancer	7.59e-05	0.000714	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Epirubicin—liver cancer	7.52e-05	0.000708	CcSEcCtD
Ibuprofen—Shock—Doxorubicin—liver cancer	7.51e-05	0.000707	CcSEcCtD
Ibuprofen—Nervous system disorder—Doxorubicin—liver cancer	7.49e-05	0.000705	CcSEcCtD
Ibuprofen—Thrombocytopenia—Doxorubicin—liver cancer	7.48e-05	0.000704	CcSEcCtD
Ibuprofen—Insomnia—Epirubicin—liver cancer	7.47e-05	0.000703	CcSEcCtD
Ibuprofen—Tachycardia—Doxorubicin—liver cancer	7.45e-05	0.000701	CcSEcCtD
Ibuprofen—Skin disorder—Doxorubicin—liver cancer	7.42e-05	0.000698	CcSEcCtD
Ibuprofen—Paraesthesia—Epirubicin—liver cancer	7.41e-05	0.000697	CcSEcCtD
Ibuprofen—Hyperhidrosis—Doxorubicin—liver cancer	7.38e-05	0.000695	CcSEcCtD
Ibuprofen—Dyspnoea—Epirubicin—liver cancer	7.36e-05	0.000692	CcSEcCtD
Ibuprofen—Somnolence—Epirubicin—liver cancer	7.34e-05	0.000691	CcSEcCtD
Ibuprofen—Anorexia—Doxorubicin—liver cancer	7.28e-05	0.000685	CcSEcCtD
Ibuprofen—Dyspepsia—Epirubicin—liver cancer	7.27e-05	0.000684	CcSEcCtD
Ibuprofen—Decreased appetite—Epirubicin—liver cancer	7.18e-05	0.000675	CcSEcCtD
Ibuprofen—Hypotension—Doxorubicin—liver cancer	7.14e-05	0.000672	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Epirubicin—liver cancer	7.13e-05	0.000671	CcSEcCtD
Ibuprofen—Fatigue—Epirubicin—liver cancer	7.12e-05	0.00067	CcSEcCtD
Ibuprofen—Constipation—Epirubicin—liver cancer	7.06e-05	0.000664	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Doxorubicin—liver cancer	6.96e-05	0.000655	CcSEcCtD
Ibuprofen—Insomnia—Doxorubicin—liver cancer	6.91e-05	0.00065	CcSEcCtD
Ibuprofen—Paraesthesia—Doxorubicin—liver cancer	6.86e-05	0.000645	CcSEcCtD
Ibuprofen—Dyspnoea—Doxorubicin—liver cancer	6.81e-05	0.000641	CcSEcCtD
Ibuprofen—Feeling abnormal—Epirubicin—liver cancer	6.8e-05	0.00064	CcSEcCtD
Ibuprofen—Somnolence—Doxorubicin—liver cancer	6.79e-05	0.000639	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Epirubicin—liver cancer	6.75e-05	0.000635	CcSEcCtD
Ibuprofen—Dyspepsia—Doxorubicin—liver cancer	6.72e-05	0.000633	CcSEcCtD
Ibuprofen—Decreased appetite—Doxorubicin—liver cancer	6.64e-05	0.000625	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Doxorubicin—liver cancer	6.59e-05	0.00062	CcSEcCtD
Ibuprofen—Fatigue—Doxorubicin—liver cancer	6.58e-05	0.00062	CcSEcCtD
Ibuprofen—Urticaria—Epirubicin—liver cancer	6.56e-05	0.000617	CcSEcCtD
Ibuprofen—Constipation—Doxorubicin—liver cancer	6.53e-05	0.000615	CcSEcCtD
Ibuprofen—Abdominal pain—Epirubicin—liver cancer	6.53e-05	0.000614	CcSEcCtD
Ibuprofen—Feeling abnormal—Doxorubicin—liver cancer	6.29e-05	0.000592	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Doxorubicin—liver cancer	6.25e-05	0.000588	CcSEcCtD
Ibuprofen—Hypersensitivity—Epirubicin—liver cancer	6.08e-05	0.000572	CcSEcCtD
Ibuprofen—Urticaria—Doxorubicin—liver cancer	6.07e-05	0.000571	CcSEcCtD
Ibuprofen—Abdominal pain—Doxorubicin—liver cancer	6.04e-05	0.000568	CcSEcCtD
Ibuprofen—Asthenia—Epirubicin—liver cancer	5.92e-05	0.000557	CcSEcCtD
Ibuprofen—Pruritus—Epirubicin—liver cancer	5.84e-05	0.00055	CcSEcCtD
Ibuprofen—Diarrhoea—Epirubicin—liver cancer	5.65e-05	0.000531	CcSEcCtD
Ibuprofen—Hypersensitivity—Doxorubicin—liver cancer	5.63e-05	0.000529	CcSEcCtD
Ibuprofen—Asthenia—Doxorubicin—liver cancer	5.48e-05	0.000516	CcSEcCtD
Ibuprofen—Dizziness—Epirubicin—liver cancer	5.46e-05	0.000514	CcSEcCtD
Ibuprofen—Pruritus—Doxorubicin—liver cancer	5.4e-05	0.000508	CcSEcCtD
Ibuprofen—Vomiting—Epirubicin—liver cancer	5.25e-05	0.000494	CcSEcCtD
Ibuprofen—Diarrhoea—Doxorubicin—liver cancer	5.23e-05	0.000492	CcSEcCtD
Ibuprofen—Rash—Epirubicin—liver cancer	5.2e-05	0.00049	CcSEcCtD
Ibuprofen—Dermatitis—Epirubicin—liver cancer	5.2e-05	0.000489	CcSEcCtD
Ibuprofen—Headache—Epirubicin—liver cancer	5.17e-05	0.000487	CcSEcCtD
Ibuprofen—Dizziness—Doxorubicin—liver cancer	5.05e-05	0.000475	CcSEcCtD
Ibuprofen—Nausea—Epirubicin—liver cancer	4.9e-05	0.000461	CcSEcCtD
Ibuprofen—Vomiting—Doxorubicin—liver cancer	4.86e-05	0.000457	CcSEcCtD
Ibuprofen—Rash—Doxorubicin—liver cancer	4.82e-05	0.000453	CcSEcCtD
Ibuprofen—Dermatitis—Doxorubicin—liver cancer	4.81e-05	0.000453	CcSEcCtD
Ibuprofen—Headache—Doxorubicin—liver cancer	4.78e-05	0.00045	CcSEcCtD
Ibuprofen—Nausea—Doxorubicin—liver cancer	4.54e-05	0.000427	CcSEcCtD
Ibuprofen—ALB—Metabolism—GOT2—liver cancer	3.76e-06	2.52e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—PIK3CB—liver cancer	3.76e-06	2.52e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—PIK3CA—liver cancer	3.71e-06	2.49e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—MTHFR—liver cancer	3.69e-06	2.47e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—RAF1—liver cancer	3.68e-06	2.47e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—TP53—liver cancer	3.68e-06	2.46e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PPARG—liver cancer	3.67e-06	2.46e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PPARG—liver cancer	3.67e-06	2.46e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PIK3CG—liver cancer	3.66e-06	2.45e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.66e-06	2.45e-05	CbGpPWpGaD
Ibuprofen—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	3.63e-06	2.43e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PPARA—liver cancer	3.62e-06	2.42e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—GSTP1—liver cancer	3.6e-06	2.41e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—MTOR—liver cancer	3.6e-06	2.41e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—PIK3CB—liver cancer	3.6e-06	2.41e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—PIK3CB—liver cancer	3.58e-06	2.4e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PIK3CD—liver cancer	3.58e-06	2.4e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.58e-06	2.4e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—CYP2E1—liver cancer	3.55e-06	2.38e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—HMOX1—liver cancer	3.55e-06	2.38e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—HPGDS—liver cancer	3.55e-06	2.38e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PPARG—liver cancer	3.54e-06	2.37e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—CYP2E1—liver cancer	3.53e-06	2.37e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—ALB—liver cancer	3.53e-06	2.37e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.53e-06	2.36e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—PIK3CA—liver cancer	3.53e-06	2.36e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.52e-06	2.36e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—HRAS—liver cancer	3.52e-06	2.36e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—MTHFR—liver cancer	3.49e-06	2.34e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—TERT—liver cancer	3.48e-06	2.34e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.48e-06	2.33e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PSMD10—liver cancer	3.47e-06	2.32e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PSMA4—liver cancer	3.47e-06	2.32e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—IL2—liver cancer	3.45e-06	2.31e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.44e-06	2.31e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—HRAS—liver cancer	3.43e-06	2.3e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—RAF1—liver cancer	3.43e-06	2.3e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.42e-06	2.29e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—PIK3CB—liver cancer	3.39e-06	2.27e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PSMD10—liver cancer	3.39e-06	2.27e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PSMA4—liver cancer	3.39e-06	2.27e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GOT2—liver cancer	3.37e-06	2.26e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CDKN1B—liver cancer	3.37e-06	2.26e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—IL6—liver cancer	3.37e-06	2.26e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—PIK3CB—liver cancer	3.35e-06	2.25e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—MTOR—liver cancer	3.35e-06	2.25e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PIK3CD—liver cancer	3.34e-06	2.24e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PIK3CD—liver cancer	3.34e-06	2.24e-05	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—AKT1—liver cancer	3.34e-06	2.24e-05	CbGpPWpGaD
Ibuprofen—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	3.33e-06	2.23e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—CYCS—liver cancer	3.33e-06	2.23e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—GSTM1—liver cancer	3.31e-06	2.22e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CASP3—liver cancer	3.31e-06	2.22e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—CYCS—liver cancer	3.31e-06	2.22e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—IL2—liver cancer	3.3e-06	2.21e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—ALB—liver cancer	3.3e-06	2.21e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—ALB—liver cancer	3.3e-06	2.21e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GOT2—liver cancer	3.29e-06	2.21e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—IL6—liver cancer	3.29e-06	2.2e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HRAS—liver cancer	3.26e-06	2.19e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—GGT1—liver cancer	3.26e-06	2.19e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—GOT1—liver cancer	3.26e-06	2.19e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.25e-06	2.18e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—GGT1—liver cancer	3.24e-06	2.17e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—GOT1—liver cancer	3.24e-06	2.17e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	3.23e-06	2.16e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PIK3CD—liver cancer	3.22e-06	2.16e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CCND1—liver cancer	3.22e-06	2.16e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.21e-06	2.15e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—JUN—liver cancer	3.21e-06	2.15e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CTNNB1—liver cancer	3.19e-06	2.14e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—ALB—liver cancer	3.18e-06	2.13e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—CYP2E1—liver cancer	3.17e-06	2.13e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.17e-06	2.13e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PSMA4—liver cancer	3.16e-06	2.12e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PSMD10—liver cancer	3.16e-06	2.12e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CDKN1B—liver cancer	3.15e-06	2.11e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—CYP1A1—liver cancer	3.14e-06	2.1e-05	CbGpPWpGaD
Ibuprofen—PPARG—Gene Expression—MYC—liver cancer	3.13e-06	2.1e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—MMP9—liver cancer	3.13e-06	2.09e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IL6—liver cancer	3.12e-06	2.09e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PIK3CB—liver cancer	3.12e-06	2.09e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CDKN1A—liver cancer	3.11e-06	2.09e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—AKT1—liver cancer	3.1e-06	2.08e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—CYP2E1—liver cancer	3.1e-06	2.08e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PIK3CG—liver cancer	3.1e-06	2.08e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GOT2—liver cancer	3.08e-06	2.06e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.07e-06	2.06e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—MAPK8—liver cancer	3.04e-06	2.04e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—AKT1—liver cancer	3.03e-06	2.03e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PPARG—liver cancer	2.99e-06	2e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CTNNB1—liver cancer	2.97e-06	1.99e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—CYCS—liver cancer	2.97e-06	1.99e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—APC—liver cancer	2.94e-06	1.97e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—VEGFA—liver cancer	2.93e-06	1.97e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—GSTP1—liver cancer	2.93e-06	1.96e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—MTHFR—liver cancer	2.93e-06	1.96e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.92e-06	1.96e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—GSTP1—liver cancer	2.91e-06	1.95e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GGT1—liver cancer	2.91e-06	1.95e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GOT1—liver cancer	2.91e-06	1.95e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PIK3CB—liver cancer	2.91e-06	1.95e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PIK3CB—liver cancer	2.91e-06	1.95e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CDKN1A—liver cancer	2.9e-06	1.95e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—CYCS—liver cancer	2.9e-06	1.94e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—CYP2E1—liver cancer	2.89e-06	1.94e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—HMOX1—liver cancer	2.89e-06	1.94e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—AKT1—liver cancer	2.88e-06	1.93e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—HMOX1—liver cancer	2.87e-06	1.93e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PPARA—liver cancer	2.87e-06	1.92e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GGT1—liver cancer	2.84e-06	1.91e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GOT1—liver cancer	2.84e-06	1.91e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PIK3CB—liver cancer	2.81e-06	1.88e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—VEGFA—liver cancer	2.81e-06	1.88e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.8e-06	1.88e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—STAT3—liver cancer	2.78e-06	1.86e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—BRAF—liver cancer	2.76e-06	1.85e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PIK3CD—liver cancer	2.72e-06	1.82e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—CYCS—liver cancer	2.71e-06	1.81e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—GSTM1—liver cancer	2.69e-06	1.81e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—TGFB1—liver cancer	2.69e-06	1.8e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—ALB—liver cancer	2.69e-06	1.8e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—GSTM1—liver cancer	2.68e-06	1.8e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GOT1—liver cancer	2.66e-06	1.78e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GGT1—liver cancer	2.66e-06	1.78e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GSTP1—liver cancer	2.62e-06	1.75e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—STAT3—liver cancer	2.59e-06	1.74e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—MYC—liver cancer	2.58e-06	1.73e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—PIK3CD—liver cancer	2.58e-06	1.73e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—HMOX1—liver cancer	2.58e-06	1.73e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.58e-06	1.73e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—TGFB1—liver cancer	2.58e-06	1.73e-05	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—PIK3CA—liver cancer	2.57e-06	1.72e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GSTP1—liver cancer	2.55e-06	1.71e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—CYP1A1—liver cancer	2.55e-06	1.71e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—SERPINE1—liver cancer	2.55e-06	1.71e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—CYP1A1—liver cancer	2.54e-06	1.7e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—HMOX1—liver cancer	2.52e-06	1.69e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—KRAS—liver cancer	2.49e-06	1.67e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PIK3CG—liver cancer	2.46e-06	1.65e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—MYC—liver cancer	2.41e-06	1.61e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GSTM1—liver cancer	2.4e-06	1.61e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—TGFB1—liver cancer	2.4e-06	1.61e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—KRAS—liver cancer	2.39e-06	1.6e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GSTP1—liver cancer	2.39e-06	1.6e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—MTHFR—liver cancer	2.38e-06	1.6e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PIK3CB—liver cancer	2.37e-06	1.59e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PPARG—liver cancer	2.37e-06	1.59e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—MTHFR—liver cancer	2.37e-06	1.59e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—HMOX1—liver cancer	2.35e-06	1.58e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GSTM1—liver cancer	2.35e-06	1.57e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PPARA—liver cancer	2.34e-06	1.57e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PPARA—liver cancer	2.32e-06	1.56e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—RAF1—liver cancer	2.3e-06	1.54e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—PIK3CA—liver cancer	2.29e-06	1.54e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—CYP1A1—liver cancer	2.28e-06	1.53e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—PIK3CB—liver cancer	2.25e-06	1.51e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—MTOR—liver cancer	2.25e-06	1.51e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—CYP1A1—liver cancer	2.22e-06	1.49e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—KRAS—liver cancer	2.22e-06	1.49e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—TP53—liver cancer	2.22e-06	1.49e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GSTM1—liver cancer	2.19e-06	1.47e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—PIK3CA—liver cancer	2.19e-06	1.47e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—PIK3CA—liver cancer	2.18e-06	1.46e-05	CbGpPWpGaD
Ibuprofen—PPARG—Gene Expression—AKT1—liver cancer	2.17e-06	1.45e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PIK3CD—liver cancer	2.16e-06	1.45e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—ALB—liver cancer	2.13e-06	1.43e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—MTHFR—liver cancer	2.12e-06	1.42e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—TP53—liver cancer	2.12e-06	1.42e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—HRAS—liver cancer	2.12e-06	1.42e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CDKN1B—liver cancer	2.11e-06	1.41e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.1e-06	1.41e-05	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—AKT1—liver cancer	2.1e-06	1.41e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.09e-06	1.4e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PPARA—liver cancer	2.08e-06	1.4e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—CYP1A1—liver cancer	2.08e-06	1.39e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—MTHFR—liver cancer	2.07e-06	1.39e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—PIK3CA—liver cancer	2.06e-06	1.38e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—PIK3CA—liver cancer	2.04e-06	1.37e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PPARA—liver cancer	2.03e-06	1.36e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—HRAS—liver cancer	2.03e-06	1.36e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PIK3CG—liver cancer	2e-06	1.34e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CTNNB1—liver cancer	1.99e-06	1.34e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PIK3CG—liver cancer	1.99e-06	1.33e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CDKN1A—liver cancer	1.95e-06	1.31e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—IL6—liver cancer	1.94e-06	1.3e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—MTHFR—liver cancer	1.94e-06	1.3e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PPARG—liver cancer	1.93e-06	1.29e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PPARG—liver cancer	1.92e-06	1.29e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PIK3CA—liver cancer	1.9e-06	1.27e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PPARA—liver cancer	1.9e-06	1.27e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—HRAS—liver cancer	1.89e-06	1.27e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PIK3CB—liver cancer	1.88e-06	1.26e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.87e-06	1.26e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—AKT1—liver cancer	1.87e-06	1.25e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—IL6—liver cancer	1.81e-06	1.21e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—AKT1—liver cancer	1.79e-06	1.2e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PIK3CG—liver cancer	1.79e-06	1.2e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—AKT1—liver cancer	1.78e-06	1.2e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PIK3CA—liver cancer	1.77e-06	1.19e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PIK3CA—liver cancer	1.77e-06	1.19e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PIK3CD—liver cancer	1.76e-06	1.18e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PIK3CD—liver cancer	1.75e-06	1.17e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PIK3CG—liver cancer	1.74e-06	1.17e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—STAT3—liver cancer	1.74e-06	1.16e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—ALB—liver cancer	1.74e-06	1.16e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PPARG—liver cancer	1.72e-06	1.15e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PIK3CA—liver cancer	1.71e-06	1.15e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.71e-06	1.14e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—AKT1—liver cancer	1.69e-06	1.13e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PPARG—liver cancer	1.68e-06	1.13e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—AKT1—liver cancer	1.67e-06	1.12e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PIK3CG—liver cancer	1.63e-06	1.09e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—MYC—liver cancer	1.62e-06	1.08e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—TGFB1—liver cancer	1.61e-06	1.08e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PPARG—liver cancer	1.57e-06	1.05e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PIK3CD—liver cancer	1.57e-06	1.05e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—AKT1—liver cancer	1.55e-06	1.04e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—ALB—liver cancer	1.55e-06	1.04e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PIK3CB—liver cancer	1.53e-06	1.03e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PIK3CD—liver cancer	1.53e-06	1.03e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PIK3CB—liver cancer	1.52e-06	1.02e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—ALB—liver cancer	1.51e-06	1.01e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—KRAS—liver cancer	1.49e-06	1e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—AKT1—liver cancer	1.45e-06	9.72e-06	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—AKT1—liver cancer	1.45e-06	9.72e-06	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PIK3CA—liver cancer	1.45e-06	9.69e-06	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PIK3CD—liver cancer	1.43e-06	9.59e-06	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—ALB—liver cancer	1.41e-06	9.47e-06	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—AKT1—liver cancer	1.4e-06	9.37e-06	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—PIK3CA—liver cancer	1.37e-06	9.19e-06	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PIK3CB—liver cancer	1.37e-06	9.17e-06	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PIK3CB—liver cancer	1.34e-06	8.95e-06	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—HRAS—liver cancer	1.27e-06	8.5e-06	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PIK3CB—liver cancer	1.25e-06	8.36e-06	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—IL6—liver cancer	1.21e-06	8.14e-06	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—AKT1—liver cancer	1.18e-06	7.92e-06	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PIK3CA—liver cancer	1.15e-06	7.7e-06	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—AKT1—liver cancer	1.12e-06	7.51e-06	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—AKT1—liver cancer	9.38e-07	6.29e-06	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PIK3CA—liver cancer	9.34e-07	6.26e-06	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PIK3CA—liver cancer	9.29e-07	6.23e-06	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PIK3CA—liver cancer	8.34e-07	5.59e-06	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PIK3CA—liver cancer	8.14e-07	5.46e-06	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—AKT1—liver cancer	7.63e-07	5.12e-06	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PIK3CA—liver cancer	7.6e-07	5.1e-06	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—AKT1—liver cancer	7.59e-07	5.09e-06	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—AKT1—liver cancer	6.81e-07	4.57e-06	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—AKT1—liver cancer	6.65e-07	4.46e-06	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—AKT1—liver cancer	6.21e-07	4.16e-06	CbGpPWpGaD
